Drug Discovery & Development highlights HealthMyne in 10 trends that will matter for pharma in 2021

December 21, 2020 | Coverage

The article highlights the most relevant trends that can follow COVID's breakneck speed to accelerate the rate of change for pharma and life sciences fields. Hear a key prediction from Rose Higgins, CEO at HealthMyne Inc., which discusses how radiomics will gain ground in drug development and clinical trials.